Implementation of an Interleukin-2 National Registry: an opportunity to improve cancer outcomes

Cancer registries have proven valuable with respect to validating therapeutic safety and drug efficacy, uncovering real-world implementation practices, and their evolution over time. Modern cancer therapeutics are approved as single agents oftentimes compared to the least active approved standard ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Michael K, Kaufman, Howard L, Daniels, Gregory A, McDermott, David F, Aung, Sandra, Lowder, James N, Morse, Michael A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100489/
https://www.ncbi.nlm.nih.gov/pubmed/25031835
http://dx.doi.org/10.1186/2051-1426-2-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100489/
https://www.ncbi.nlm.nih.gov/pubmed/25031835
http://dx.doi.org/10.1186/2051-1426-2-20

Ejemplares similares